Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Construction in Progress (2016 - 2025)

Heron Therapeutics filings provide 13 years of Construction in Progress readings, the most recent being $1.7 million for Q4 2025.

  • On a quarterly basis, Construction in Progress fell 34.62% to $1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.7 million, a 34.62% decrease, with the full-year FY2025 number at $1.7 million, down 34.62% from a year prior.
  • Construction in Progress hit $1.7 million in Q4 2025 for Heron Therapeutics, down from $2.6 million in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $15.9 million in Q4 2021 to a low of $1.7 million in Q4 2025.
  • Median Construction in Progress over the past 5 years was $5.4 million (2022), compared with a mean of $6.4 million.
  • Biggest five-year swings in Construction in Progress: crashed 66.04% in 2022 and later rose 16.67% in 2023.
  • Heron Therapeutics' Construction in Progress stood at $15.9 million in 2021, then crashed by 66.04% to $5.4 million in 2022, then increased by 16.67% to $6.3 million in 2023, then plummeted by 58.73% to $2.6 million in 2024, then plummeted by 34.62% to $1.7 million in 2025.
  • The last three reported values for Construction in Progress were $1.7 million (Q4 2025), $2.6 million (Q4 2024), and $6.3 million (Q4 2023) per Business Quant data.